L-Propargylglycine is a non-proteinogenic amino acid derivative characterized by the presence of a propargyl group (-C≡CH) attached to the alpha-carbon of glycine. It serves as a potent, irreversible, and mechanism-based inhibitor of the enzyme cystathionine γ-lyase (CSE). This inhibition is achieved through the formation of a covalent adduct with the enzyme's pyridoxal phosphate cofactor, effectively blocking the production of hydrogen sulfide (H₂S) from L-cysteine. Due to its specific inhibitory action, L-propargylglycine is a crucial research tool in life science and biomedical studies. It is widely used to investigate the physiological and pathological roles of endogenous H₂S, a gasotransmitter involved in processes such as vasodilation, inflammation, neurotransmission, and cell survival. Its application helps delineate the signaling pathways of H₂S in various disease models, including cardiovascular disorders, neurological conditions, and cancer. Beyond its primary role as a biochemical probe, the compound's structure, featuring both an amino acid backbone and a terminal alkyne, makes it a valuable building block in synthetic chemistry. The alkyne group readily participates in click chemistry reactions, such as the copper-catalyzed azide-alkyne cycloaddition (CuAAC), enabling its use for bioconjugation, peptide modification, and the synthesis of more complex molecules for chemical biology research.